Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Butylhydroxyanisole (BHA) for Oxidative Stress Assays
2026-09-07
Butylhydroxyanisole (BHA) gives researchers a controllable way to probe free-radical biology across ROS, viability, and apoptosis workflows. This guide emphasizes solvent discipline, timing controls, orthogonal readouts, and practical lessons from peptide research that improve assay interpretation.
-
Fzd5 Links Cholesterol to Wnt Signaling in PDAC
2026-09-07
The reference study identifies Frizzled5 as a cholesterol-sensitive Wnt receptor that connects lipid metabolism with β-catenin signaling in pancreatic ductal adenocarcinoma. Its results indicate that cholesterol-dependent receptor maturation may be therapeutically opposed by 25-hydroxysterol, while also providing a mechanistic framework for studying receptor trafficking and signaling with complementary biochemical workflows.
-
7-Ethyl-10-hydroxycamptothecin Workflow Guide
2026-09-05
Build more informative colon cancer assays with 7-Ethyl-10-hydroxycamptothecin (SN-38), combining topoisomerase I inhibition, cell-cycle profiling, and apoptosis measurements. This workflow also adapts the FUBP1–FUSE binding assay described in the literature, helping distinguish direct mechanistic effects from nonspecific cytotoxicity.
-
Fe3O4@ZIF-8 for Jaw Osteomyelitis
2026-09-04
The reference study presents Fe3O4@ZIF-8 core–shell nanoparticles as a dual-function strategy for jaw osteomyelitis, combining pH-responsive Zn2+ release for antibacterial activity with magnetically supported bone regeneration. Its main innovation is the coordination of bacterial membrane disruption, heat-shock suppression, and osteogenic effects within one nanomaterial platform.
-
PreScission Protease: From Tag Cleavage to Assay Design
2026-09-04
PreScission Protease enables sequence-specific HRV 3C protease cleavage at low temperature. This guide connects fusion-tag engineering with assay design, using a Drosophila nuclear-architecture study to show how purified proteins can support stronger mechanistic conclusions.
-
CCG-1423: Reading RhoA Signaling in Context
2026-09-03
CCG-1423 is a RhoA inhibitor that helps separate transcriptional signaling from ROCK-dependent cytoskeletal effects. This article interprets its mechanism alongside new evidence on RhoA/ROCK signaling, tight-junction remodeling, cancer research, and apoptosis assay design.
-
Leucomycin: From Chemical Quality to Assay Insight
2026-09-03
Leucomycin (kitasamycin) is more than a macrolide antibiotic: its multicomponent composition directly shapes assay interpretation. This guide connects analytical quality control with translational inhibition studies, bacterial growth inhibition assays, and macrolide resistance characterization.
-
NBC19: NLRP3 Inflammasome Workflow Guide
2026-09-02
NBC19 supports nanomolar interrogation of NLRP3 signaling in differentiated THP-1 cells, with distinct use cases for Nigericin- and ATP-induced inflammasome activation. This guide combines assay design, compound-handling controls, lactate–HMGB1 biology, and troubleshooting strategies for reproducible inflammation research.
-
BHA as a Translational Redox Control
2026-09-02
Butylated hydroxyanisole (BHA) is more than a generic antioxidant control: used deliberately, it can help translational researchers distinguish reactive oxygen species effects from assay artifacts, cytotoxicity, and downstream pathway changes. This thought-leadership article connects BHA workflow design with lessons from peptide drug development, emphasizing reproducibility, mechanistic restraint, and decision-ready evidence.
-
Perospirone: SM-9018 Free Base Assay Guide
2026-09-01
Build more informative antipsychotic mechanism studies with Perospirone by pairing 5-HT2A, D2, and 5-HT1A pharmacology with a practical Kv1.5 off-target workflow. This guide connects neuropsychiatric disorder models to vascular electrophysiology while emphasizing solvent control, concentration selection, and assay troubleshooting.
-
EGF Signaling as a Translational Assay Lever
2026-09-01
Recombinant human EGF is more than a routine cell-culture supplement. This thought-leadership article explains how defined EGF receptor binding can improve assay reproducibility, sharpen interpretation of cell proliferation and differentiation, and support translational studies that distinguish growth-factor context from cancer-cell dependency. It also connects disciplined EGF assay design with recent chemogenetic evidence identifying EphA2 as a synthetic lethal vulnerability in MYC-driven triple-negative breast cancer.
-
CLCC1 Drives Herpesvirus Nuclear Egress Fusion
2026-08-31
A 2024 bioRxiv preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion step of herpesvirus nuclear egress. Genetic screening, cell biology, and evolutionary analysis connect CLCC1 loss with perinuclear capsid accumulation, impaired nuclear pore insertion, and reduced viral production, while also suggesting a broader role in nuclear-envelope morphogenesis.
-
Mianserin HCl in Applied Receptor Research
2026-08-31
Mianserin HCl provides a practical pharmacological probe for 5-HT2 signaling, noradrenergic modulation, and psychiatric disorder research. Its emerging use in β-cyclodextrin complexation and antipathogenic assays makes it more than a conventional antidepressant research compound, but each application requires careful controls.
-
Dacomitinib and the Ferroptosis Research Frontier
2026-08-30
Dacomitinib (PF-00299804) offers translational researchers a powerful way to interrogate irreversible pan-HER signaling blockade, resistance biology, and cancer cell fate. This article connects its established EGFR, HER2, and HER4 activity with the mitochondrial ferroptosis findings reported for METTL17 in colorectal cancer, while clearly separating evidence from forward-looking hypotheses.
-
Streptavidin-Cy3 for NPC Metastasis Assays
2026-08-29
Use Streptavidin-Cy3 to convert biotinylated antibodies, nucleic-acid probes, and proteins into a bright Cy3 signal across NPC imaging and flow workflows. This guide connects super-enhancer RNA biology with practical assay design, controls, optimization, and interpretation limits.